Practical Considerations for Use of Direct Oral Anticoagulants in Children

Direct oral anticoagulants (DOACs) provide an attractive alternative for the management and prevention of thrombosis in pediatric patients. With multiple ongoing and published pediatric trials and recent regulatory approval of dabigatran and rivaroxaban, the landscape of pediatric anticoagulation is...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitworth, Hilary, Raffini, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010784/
https://www.ncbi.nlm.nih.gov/pubmed/35433559
http://dx.doi.org/10.3389/fped.2022.860369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010784/
https://www.ncbi.nlm.nih.gov/pubmed/35433559
http://dx.doi.org/10.3389/fped.2022.860369

Ejemplares similares